Abstract
Purpose
To assess the knowledge of generalist OB/GYN providers on aneuploidy screening recommendations for patients who utilized preimplantation genetic testing, and to survey providers’ current practice habits.
Methods
A 12-question survey was distributed by email to OB/GYN physicians in the USA. Demographic information was also collected.
Results
A total of 178 survey responses were included for analysis. Sixty-seven percent correctly identified the current ACOG recommendation to offer additional aneuploidy screening/invasive diagnostic testing regardless of PGT status, and 66% said their practice is consistent with this recommendation. Ninety-one percent of responders correctly answered that in vitro fertilization does not always include PGT and 63% of responders were able to correctly identify the 3 available types of PGT. Thirty-three percent (n = 58) were attending physicians, and 67% (n = 120) were resident physicians. Most participants (81%, n = 145) stated they have been in practice 0–9 years, and the remaining 19% (n = 33) stated they have been in practice ≥ 10 years.
Conclusion
Significant knowledge gaps of PGT and aneuploidy screening recommendations after PGT exist among generalist OB/GYN physicians. Efforts should be made to educate providers on the importance of offering aneuploidy screening and diagnostic testing to patients who utilized PGT to improve patient care.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data Availability
The data in the current study are available from the corresponding author on reasonable request.
References
Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2015 assisted reproductive technology national summary report. Atlanta (GA): US Dept of Health and Human Services; 2017. https://www.cdc.gov/art/pdf/2015-report/ART-2015-National-Summary-Report.pdf.
Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2018 assisted reproductive technology fertility clinic success rates report. Atlanta: US Dept of Health and Human Services; 2021. Available from: https://www.cdc.gov/art/artdata/index.html#reports. Accessed 23 Oct 2021
Roche K, Racowsky C, Harper J. Utilization of preimplantation genetic testing in the USA. J Assist Reprod Genet. 2021;38:1045–53. https://doi.org/10.1007/s10815-021-02078-4.
Simopoulou M, Sfakianoudis K, Maziotis E, et al. PGT-A: who and when? Α systematic review and network meta-analysis of RCTs. J Assist Reprod Genet. 2021;38:1939–57. https://doi.org/10.1007/s10815-021-02227-9.
Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion. Fertil Steril. 2018;109(3):429–36. https://doi.org/10.1016/j.fertnstert.2018.01.002.
Yan J, Qin Y, Zhao H, et al. Live birth with or without preimplantation genetic testing for aneuploidy. N Engl J Med. 2021;385(22):2047–58. https://doi.org/10.1056/NEJMoa2103613.
Haviland MJ, Murphy LA, Modest AM, et al. Comparison of pregnancy outcomes following preimplantation genetic testing for aneuploidy using a matched propensity score design. Hum Reprod. 2020;35(10):2356–64. https://doi.org/10.1093/humrep/deaa161.
Screening for fetal chromosomal abnormalities. ACOG Practice Bulletin No. 226. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2020;136:e48-69.9. https://doi.org/10.1097/AOG.0000000000004084.
Preimplantation genetic testing. ACOG Committee Opinion Summary, Number 799. Obstet Gynecol. 2020;135(3):752–3. https://doi.org/10.1097/AOG.0000000000003715.
Munné S, Lee A, Rosenwaks Z, et al. Diagnosis of major chromosome aneuploidies in human preimplantation embryos. Hum Reprod. 1993;8:2185–91. https://doi.org/10.1093/oxfordjournals.humrep.a138001.
Practice Bulletin No. 163: Screening for fetal aneuploidy. Obstet Gynecol. 2016;127(5):e123–37. https://doi.org/10.1097/AOG.0000000000001406.
Klimczak AM, Reig A, Neal SA, Seli E, Scott RT Jr. Interpretation of noninvasive prenatal testing results following in vitro fertilization and preimplantation genetic testing for aneuploidy. Am J Obstet Gynecol MFM. 2020;2(4):100232. https://doi.org/10.1016/j.ajogmf.2020.100232.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Lisa McNamee. The first draft of the manuscript was written by Lisa McNamee, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
McNamee, L., Clark, S. & Suskin, B. Aneuploidy screening after preimplantation genetic testing: a national survey of physician knowledge and practice. J Assist Reprod Genet 40, 665–669 (2023). https://doi.org/10.1007/s10815-023-02716-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-023-02716-z